ASSOCIATIONS OF METABOLIC SUBTYPES OF METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE WITH RISK OF CARDIOVASCULAR MORTALITY AND ALL-CAUSE MORTALITY IN THE UNITED STATES

被引：0
|
作者：
Zeng, Guyu [1 ]
Wang, Peizhi [1 ]
Yuan, Jinqing [1 ]
机构：
[1] Fuwai Hosp, Beijing, Peoples R China
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1453-207
引用
收藏
页码：1968 / 1968
页数：1
相关论文
共 50 条
  • [41] All-cause and cardiovascular disease mortality increased with metabolic syndrome in Taiwanese
    Huang, Kuo-Chin
    Lee, Long-Teng
    Chen, Ching-Yu
    Sung, Pei-Kun
    OBESITY, 2008, 16 (03) : 684 - 689
  • [42] Atherosclerotic cardiovascular disease risk difference in metabolic dysfunction-associated fatty liver disease and nonalcoholic fatty liver disease
    Tamaki, Nobuharu
    Kurosaki, Masayuki
    Higuchi, Mayu
    Izumi, Namiki
    HEPATOLOGY RESEARCH, 2021, 51 (11) : 1172 - 1173
  • [43] Metabolic dysfunction-associated steatotic liver disease and risk of cardiovascular disease
    Lee, Hyeok-Hee
    Lee, Han Ah
    Kim, Eun-Jin
    Kim, Hwi Young
    Kim, Hyeon Chang
    Ahn, Sang Hoon
    Lee, Hokyou
    Kim, Seung Up
    GUT, 2024, 73 (03) : 533 - 540
  • [44] Metabolic dysfunction-associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortality
    van Kleef, Laurens A.
    de Knegt, Robert J.
    Brouwer, Willem Pieter
    HEPATOLOGY, 2023, 77 (03) : 942 - 948
  • [45] Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-Rather a Bystander Than a Driver of Mortality
    Semmler, Georg
    Wernly, Sarah
    Bachmayer, Sebastian
    Leitner, Isabella
    Wernly, Bernhard
    Egger, Matthias
    Schwenoha, Lena
    Datz, Leonora
    Balcar, Lorenz
    Semmler, Marie
    Stickel, Felix
    Niederseer, David
    Aigner, Elmar
    Datz, Christian
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (09): : 2670 - 2677
  • [46] Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the United States
    Kim, Donghee
    Wijarnpreecha, Karn
    Sandhu, Keeryth K.
    Cholankeril, George
    Ahmed, Aijaz
    LIVER INTERNATIONAL, 2021, 41 (08) : 1832 - 1840
  • [47] Metabolic Dysfunction-Associated Fatty Liver Disease and Mortality: A Population-Based Cohort Study
    Kim, Kyung-Soo
    Hong, Sangmo
    Ahn, Hong-Yup
    Park, Cheol-Young
    DIABETES & METABOLISM JOURNAL, 2023, 47 (02) : 220 - 231
  • [48] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E14 - E14
  • [49] Association of healthy lifestyles with risk of all-cause and cause-specific mortality among individuals with metabolic dysfunction-associated steatotic liver disease: results from the DFTJ cohort
    Deng, Qilin
    Zhang, Yingchen
    Guan, Xin
    Wang, Chenming
    Guo, Huan
    ANNALS OF MEDICINE, 2024, 56 (01)
  • [50] From metabolic dysfunction-associated fatty liver disease to metabolic dysfunction-associated steatotic liver disease: Controversy and consensus
    Chen, Li
    WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (12) : 1253 - 1257
12345